GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2016 | $244,000 | +1.7% | 5,648 | +1.8% | 0.13% | +9.2% |
| Q2 2016 | $240,000 | +6.7% | 5,548 | 0.0% | 0.12% | -7.8% |
| Q1 2016 | $225,000 | +0.4% | 5,548 | 0.0% | 0.13% | +16.2% |
| Q4 2015 | $224,000 | +5.2% | 5,548 | 0.0% | 0.11% | -2.6% |
| Q3 2015 | $213,000 | -7.8% | 5,548 | 0.0% | 0.11% | +10.7% |
| Q2 2015 | $231,000 | -9.8% | 5,548 | 0.0% | 0.10% | -6.4% |
| Q1 2015 | $256,000 | +8.0% | 5,548 | 0.0% | 0.11% | +7.8% |
| Q4 2014 | $237,000 | -7.1% | 5,548 | 0.0% | 0.10% | -10.5% |
| Q3 2014 | $255,000 | -95.4% | 5,548 | -94.6% | 0.11% | -95.2% |
| Q2 2014 | $5,536,000 | +3.1% | 103,540 | +3.1% | 2.36% | -1.6% |
| Q1 2014 | $5,367,000 | +0.5% | 100,444 | +0.4% | 2.40% | +0.3% |
| Q4 2013 | $5,342,000 | +1309.5% | 100,084 | +1226.0% | 2.39% | +1242.1% |
| Q3 2013 | $379,000 | +0.5% | 7,548 | 0.0% | 0.18% | -10.1% |
| Q2 2013 | $377,000 | – | 7,548 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |